Holen Sie sich die Stockscreener-App
1.93
1.88%
-0.04
Schlusskurs vom Vortag:
$1.97
Offen:
$1.91
24-Stunden-Volumen:
11,949
Relative Volume:
0.05
Marktkapitalisierung:
$2.82B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-8.5892
EPS:
-0.2247
Netto-Cashflow:
-
1W Leistung:
-4.78%
1M Leistung:
+19.32%
6M Leistung:
+0.42%
1J Leistung:
-35.35%
1-Tages-Spanne:
$1.8793
$1.9566
1-Wochen-Bereich:
$1.8793
$2.23
52-Wochen-Spanne:
$1.32
$3.12
Immutep Limited Adr Stock (IMMP) Company Profile
Firmenname
Immutep Limited Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IMMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
1.93 | 288.21M | 0 | 0 | 0 | 0.00 |
|
ONC
Beigene Ltd Adr
|
241.10 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.56 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.33 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.19 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.18 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-17 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-07-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-09-28 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-15 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten
Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX
Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria
Immutep stock soars on promising trial results - Investing.com Australia
Immutep Quarterly Activities Report Q3 FY25 - The Manila Times
Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au
Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest
Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World
Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times
Immutep shares new cancer study results - Investing.com
Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire
10 Best Australian Stocks To Buy - Yahoo Finance
Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology
Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks
IMMPImmutep Latest Stock News & Market Updates - Stock Titan
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance
Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus
A Full List of Australia ADRs - Investing.com Australia
Immutep (IMMP) Stock Price, News & Analysis - MarketBeat
Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia
Prima BioMed Stock Price Today | NASDAQ: IMMP Live - Investing.com
Prima BioMed Stock Price Today | NASDAQ IMMP - Investing.com Canada
ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - advfn.com
Finanzdaten der Immutep Limited Adr-Aktie (IMMP)
Es liegen keine Finanzdaten für Immutep Limited Adr (IMMP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
13.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):